Abstract

Background

We propose a comprehensive evaluation of a Discovery MI 4-ring (DMI) model, using a Monte Carlo simulator (GATE) and a clinical reconstruction software package (PET toolbox). The following performance characteristics were compared with actual measurements according to NEMA NU 2-2018 guidelines: system sensitivity, count losses and scatter fraction (SF), coincidence time resolution (CTR), spatial resolution (SR), and image quality (IQ). For SR and IQ tests, reconstruction of time-of-flight (TOF) simulated data was performed using the manufacturer’s reconstruction software.

Results

Simulated prompt, random, true, scatter and noise equivalent count rates closely matched the experimental rates with maximum relative differences of 1.6%, 5.3%, 7.8%, 6.6%, and 16.5%, respectively, in a clinical range of less than 10 kBq/mL. A 3.6% maximum relative difference was found between experimental and simulated sensitivities. The simulated spatial resolution was better than the experimental one. Simulated image quality metrics were relatively close to the experimental results.

Conclusions

The current model is able to reproduce the behaviour of the DMI count rates in the clinical range and generate clinical-like images with a reasonable match in terms of contrast and noise.

Details

Title
Validation of a discovery MI 4-ring model according to the NEMA NU 2-2018 standards: from Monte Carlo simulations to clinical-like reconstructions
Author
Merlet, Antoine 1 ; Presles, Benoît 2 ; Su, Kuan-Hao 3 ; Salvadori, Julien 4 ; Sayah, Farzam 5 ; Jozi, Hanieh 5 ; Cochet, Alexandre 6 ; Vrigneaud, Jean-Marc 6   VIAFID ORCID Logo 

 University of Burgundy, Imagerie et Vision artificielle, ImViA EA 7535, Dijon, France (GRID:grid.5613.1) (ISNI:0000 0001 2298 9313) 
 University of Burgundy, Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB), UMR CNRS 6302, Dijon, France (GRID:grid.5613.1) (ISNI:0000 0001 2298 9313) 
 GE Healthcare, Waukesha, USA (GRID:grid.418143.b) (ISNI:0000 0001 0943 0267) 
 Institut de cancérologie Strasbourg Europe, ICANS, Strasbourg, France (GRID:grid.512000.6) 
 Georges-François Leclerc Cancer Centre, Department of Nuclear Medicine, Dijon, France (GRID:grid.418037.9) (ISNI:0000 0004 0641 1257) 
 University of Burgundy, Institut de Chimie Moléculaire de l’Université de Bourgogne (ICMUB), UMR CNRS 6302, Dijon, France (GRID:grid.5613.1) (ISNI:0000 0001 2298 9313); Georges-François Leclerc Cancer Centre, Department of Nuclear Medicine, Dijon, France (GRID:grid.418037.9) (ISNI:0000 0004 0641 1257) 
Pages
13
Publication year
2024
Publication date
Dec 2024
Publisher
Springer Nature B.V.
e-ISSN
21977364
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2921278296
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.